These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13862259)

  • 1. Treatment of disseminated melanoma with phenylalanine mustard (melphelan) and autogenous bone marrow transplants.
    ARIEL IM; PACK GT
    Surgery; 1962 May; 51():583-91. PubMed ID: 13862259
    [No Abstract]   [Full Text] [Related]  

  • 2. Disseminated abdominal melanoma treated by massive dosage of nitrogen mustard and autogenous bone-marrow replacement.
    JONES KO; REEVE TS; PIPER DW; CUMBERLAND VH
    Med J Aust; 1960 Jul; 47(2)():61-3. PubMed ID: 14407740
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitrogen-mustard therapy combined with autologous marrow infusion.
    CLIFFORD P; CLIFT RA; DUFF JK
    Lancet; 1961 Apr; 1(7179):687-90. PubMed ID: 13694099
    [No Abstract]   [Full Text] [Related]  

  • 4. Disseminated malignant melanoma: response to treatment by massive dosage of a cytotoxic agent combined with autogenous marrow replacement.
    WESTBURY G; HUMBLE JG; NEWTON KA; SKINNER ME; PEGG DE
    Lancet; 1959 May; 1(7080):968-9. PubMed ID: 13655649
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrogen and phenylalanine mustard. Use in women with intrauterine cancer.
    DIDDLE AW; WATTS G; WATTS J; JENKINS HH
    Am J Obstet Gynecol; 1962 Feb; 83():490-3. PubMed ID: 13886225
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of malignant melanoma of the leg treated by isolated perfusion of nitrogen mustard].
    MANIZADE D; SALEPCIOGLU A; AKTAN K
    Turk Tip Cemiy Mecm; 1960 Nov; 26():564-9. PubMed ID: 13766186
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of malignant melanoma by perfusion techniques.
    IRVINE WT; NOON CF
    Proc R Soc Med; 1961 Jun; 54(6):483-5. PubMed ID: 13717903
    [No Abstract]   [Full Text] [Related]  

  • 8. Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets.
    CONRAD ME; CROSBY WH
    Blood; 1960 Aug; 16():1089-103. PubMed ID: 13811574
    [No Abstract]   [Full Text] [Related]  

  • 9. Further observations on the efficacy of phenylalanine mustards against mouse melanoma.
    LUCK JM
    Cancer Res; 1961 Feb; 21():262-4. PubMed ID: 13764029
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of melanoma of the extremities by isolated perfusion.
    CREECH O; KREMENTZ ET; RYAN RF
    Cancer Chemother Rep; 1962 Feb; 16():579-81. PubMed ID: 13882088
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of phenylalanine nitrogen mustard (CB 3025) in metastatic malignant melanoma of man.
    HOLLAND JF; REGELSON W
    Ann N Y Acad Sci; 1958 Apr; 68(3):1122-5. PubMed ID: 13627764
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective action of autologous marrow against nitrogen mustard toxicity.
    BLACK MM; SPEER FD; STONE ML
    Ann Intern Med; 1959 Sep; 51():517-25. PubMed ID: 13801160
    [No Abstract]   [Full Text] [Related]  

  • 13. Contributions to the treatment of cancer of the head and neck. Nitrogen mustard toxicity and bone marrow infusion.
    CLIFT RA
    East Afr Med J; 1961 Nov; 38():500-2. PubMed ID: 13879952
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow protection as a potential aid to chemotherapy.
    AMBRUS CM; BACK N; AMBRUS JL
    Acta Unio Int Contra Cancrum; 1960; 16():540-1. PubMed ID: 13793133
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of prolonged remission of lymphosarcomatosis after sarcolysin and roentgen-ray therapy].
    KRASOVSKII II; IAKOVLEV AM
    Vopr Onkol; 1960; 6(11)():84-6. PubMed ID: 13754023
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of disseminated melanoma by systemic melphalan, methotrexate and autogenous bone marrow transplants. Experience with 114 patients.
    Ariel IM; Pack GT
    Cancer; 1967 Jan; 20(1):77-85. PubMed ID: 5334533
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bone-marrow transplantation in patients with bone-marrow depression. Aplastic anemia after nitrogen mustard therapy].
    HEYL T
    S Afr Med J; 1961 Jul; 35():604-7. PubMed ID: 13714064
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow protection in mechlorethamine (nitrogen mustard) therapy.
    MILLER DG; LAWRENCE W
    Arch Surg; 1962 Sep; 85():430-41. PubMed ID: 14473972
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of melanoma by isolation-perfusion technique.
    CREECH O; RYAN RF; KREMENTZ ET
    J Am Med Assoc; 1959 Jan; 169(4):339-43. PubMed ID: 13610669
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of phenylalanine nitrogen mustard on tissues in culture.
    STUBBLEFIELD E; HSU TC
    Antibiot Chemother (Northfield); 1957 Sep; 7(9):493-6. PubMed ID: 24544534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.